Leucine enkephalin degradation in allergopathic versus normal human plasma

Immunopharmacology

Volumn 39, Issue 2, 1998, Pages 93-105

  Bongiorno, Lucilla ^a   Fuso, Lionello ^b   Marini, Mario ^a   Marzano, Marina ^a   Nardecchia, Bernardino ^a   Roda, L Giorgio ^a   Rossi, Paolo ^a   Urbani, Alessandra ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Allergic asthma; Opioid peptides; Plasma proteolytic enzymes

Indexed keywords

AMINOPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL PEPTIDASE; LEUCINE ENKEPHALIN; OPIATE PEPTIDE;

ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; BIODEGRADATION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYDROLYSIS; MALE; PLASMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; ENDOPEPTIDASES; ENKEPHALIN, LEUCINE; FEMALE; HUMANS; HYDROLYSIS; HYPERSENSITIVITY; MALE; MIDDLE AGED; PROTEASE INHIBITORS;

EID: 0031876633     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(98)00009-5     Document Type: Article

References (79)

1. Aronin, N., Wiesen, M., Liotta, A.S., Schlussler, G.C., Krieger, D.T., 1981. Comparative metabolic clearance rates of β-endorphin and β-lipotropin in humans. Life Sci. 29, 1265-1269.
2. Ausiello, C.M., Roda, L.G., 1984. Leu-enkephalin binding to cultured human T lymphocytes. Cell Biol. Int. Rep. 8, 353-362.
3. Bajpal, K., Singh, V.K., Agarwal, S.S., Dhawan, V.C., Naqvi, T., Haq, W., Mathur, K.B., 1995. Immunomodulatory activity of met-enkephalin and its two potent analogues. Int. J. Immunopharmacol. 17, 207-212.
4. Bayer, B.M., Gastonguay, M.R., Hernandez, M.C., 1992. Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 23, 117-124.
5. Bessler, H., Sztein, M.B., Serrate, S.A., 1990. β-endorphin modulation of IL-1-induced IL-2 production. Immunopharmacology 19, 5-14.
6. Bidlack, J.M., Saripalli, L.D., Lawrence, D.M.P., 1992. K-opioid binding sites on a murine lymphoma cell line. Eur. J. Pharmacol. 227, 257-265.
7. Bolacchi, F., Marini, M., Urbani, A., Roda, L.G., 1995. Enzymes and inhibitors of leu-enkephalin metabolism in human plasma. Neurochem. Res. 20, 991-999.
8. Bowes, M.A., Kenny, A.J., 1987. An immunohistochemical study of endopeptidase-24.11 and aminopeptidase N in lymphoid tissues. Immunology 60, 247-253.
9. Brown, S.L., Van Epps, D.E., 1986. Opioid peptides modulate production of interferon by human mononuclear cells. Cell. Immunol. 103, 19-26.
10. Buzzetti, R., McLoughlin, L., Lavender, P.M., Clark, A.J.L., Rees, L.H., 1989a. Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignances. J. Clin. Invest. 83, 733-737.
11. Buzzetti, R., McLoughlin, L., Scavo, D., Rees, L.H., 1989b. A critical assessment of the interactions between the immune system and the hypothalamo-pituitary-adrenal axis. J. Endocrinol. 120, 183-187.
12. Carr, D.J.J., Serou, M., 1995. Exogenous and endogenous opioids as biological response modifiers. Immunopharmacology 31, 59-71.
13. Caughey, G.H., Leidig, F., Viro, N.F., Nadel, J.A., 1988. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Pharmacol. Exp. Ther. 244, 133-137.
14. Chen, Y., Mestek, A., Liu, H., Hurley, J.A., Yu, L., 1993. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Parmacol. 44, 8-12.
15. Chiappelli, F., Yamashita, N., Faisal, M., Kemeny, M., Bullington, R., Nguyen, L., Clement, L.T., Fahey, J.L., 1991. Differential effect of β-endorphin on three human cytotoxic cell populations. Int. J. Immunopharmacol. 13, 291-297.
16. Chipkin, R.E., Coffin, V.L., 1991. Analgesic and acute central nervous system side effects of the intravenously administered enkephalinase inhibitor SCH 32615. Pharmacol. Biochem. Behav. 38, 21-27.
17. Chukwuocha, R.U., Reyes, E., Tokuda, S., 1994. The in vivo effect of opioid peptides on the murine immune response. Int. J. Immunopharmacol. 16, 205-215.
18. Connelly, J.C., Skidgel, R.A., Schultz, W.W., Johnson, A.R., Erdos, E.G., 1985. Neutral endopeptidase-24.11 in human neutrophils: cleavage of chemotactic peptide. Proc. Natl. Acad. Sci. U.S.A. 82, 8737-8741.
19. Cupps, T.R., Fauci, A.S., 1982. Corticosteroid-mediated immunoregulation in man. Immunol. Rev. 65, 133-155.
20. Dauge', V., Mauborgne, A., Casselin, F., Fournie'-Zalusky, M.-C, Roques, B.-P., 1996. The dual peptidase inhibitor RB101 induces a long-lasting increase in the extracellular level of met-enkephalin-like material in the nucleus accumbens of freely moving rats. J. Neurochem. 67, 1301-1308.
21. Demetrikopoulos, M.K., Siegel, A., Schleifer, S.J., Obedi, J., Keller, S.E., 1994. Electrical stimulation of the dorsal midbrain periaqueductal gray suppresses peripheral blood natural killer cell activity. Brain Behav. Immun. 8, 218-228.
22. Drapeau, G., Chow, A., Ward, P.E., 1991. Metabolism of bradikinin analogs by angiotensin I converting enzyme and carboxypeptidase N. Peptides 12, 631-638.
23. Fontana, L., Fattorossi, A., D'Amelio, R., Migliorati, A., Perricone, R., 1987. Modulation of human concanavalin A-induced lymphocyte proliferative response by physiological concentrations of β-endorphin. Immunopharmacology 13, 111-115.
24. Freier, D.O., Fuchs, B.A., 1994. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J. Pharmacol. Exp. Ther. 270, 1127-1133.
25. Gilman, S.C., Schwartz, J.M., Milner, R.J., Bloom, F.E., Feldman, J.D., 1982. β-endorphin enhances lymphocyte proliferative responses. Proc. Natl. Acad. Sci. U.S.A. 79, 4226-4230.
26. Guan, L., Townsend, R., Eisenstein, T.K., Adler, M.W., Rogers, T.J., 1994. Both T cells and macrophages are targets of k-opioid-induced immunosuppression. Brain Behav. Immun. 8, 229-240.
27. Hambrook, J.M., Morgan, B.A., Ranee, M.J., Smith, C.F., 1976. Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature 262, 782-783.
28. Hazum, E., Chang, K.-J., Cuatrecasas, P., 1979. Specific nonopiate receptors for β-endorphin. Science 205, 1033-1035.
29. Heijnen, C.J., Bevers, C., Kavelaars, A., Ballieux, R.E., 1986. Effect of α-endorphin on the antigen-induced primary antibody response of human blood B cells in vitro. J. Immunol. 136, 213-216.
30. Heijnen, C.J., Kavelaars, A., Ballieux, R.E., 1991. β-endorphin: cytokine and neuropeptide. Immunol. Rev. 119, 41-63.
31. Hopkins, S.J., Rottwell, N.J., 1995. Cytokines and the nervous system: I. Expression and recognition. TiNS 18, 83-88.
32. Hucklebridge, F.H., Hudspith, B.N., Lydyard, P.M., Brostoff, J., 1990. Stimulation of human peripheral lymphocytes by methionine enkephalin and δ-selective opioid analogues. Immunopharmacology 19, 87-91.
33. Johnson, H.M., Smith, E.M., Torres, B.A., Blalock, J.E., 1982. Regulation of the in vitro antibody response by neuroendocrine hormones. Proc. Natl. Acad. Sci. U.S.A. 79, 4171-4417.
34. Johnson, P.S., Wang, J.B., Wang, W.F., Uhl, G.R., 1994. Expressed mu opiate receptor couples to adenylate cyclase and phosphatidylinositol turnover. Neuroreport 12, 507-509.
35. Katoh, A., Nabeshima, T., Kameyama, T., 1990. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphins and their interactions. J. Pharmacol. Exp. Ther. 253, 600-607.
36. Kavelaars, A., Ballieux, R.E., Heijnen, C.J., 1989. The role of IL-1 in the corticotropin-releasing factor and arginine-vasopressin-induced secretion of immunoreactive β-endorphin by human peripheral blood mononuclear cells. J. Immunol. 142, 2338-2342.
37. Kavelaars, A., Ballieux, R.E., Heijnen, C.J., 1990. Differential effects of β-endorphin on cAMP levels in human peripheral blood mononuclear cells. Brain Behav. Immun. 4, 171-179.
38. Kerr, M.A., Kenny, A.J., 1974. The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem. J. 137, 477-488.
39. Kusnecov, A.W., Husband, A.J., King, M.G., Smith, R., 1989. Modulation of mitogen-induced spleen cell proliferation and the antibody-forming cell response by β-endorphin in vivo. Peptides 10, 473-479.
40. Laudenslager, M.L., Ryan, S.M., Drugan, R.C., Hyson, R.L., Maier, S.F., 1983. Coping and immunosuppression: inescapable but not escapable shock suppresses lymphocyte proliferation. Science 221, 568-570.
41. Lolait, S.J., Lim, A.T., Toh, B.H., Funder, J.W., 1984. Immunoreactive β-endorphin in a subpopulation of mouse spleen macrophages. J. Clin. Invest. 73, 277-280.
42. Lysle, D.T., Coussons, M.E., Watts, V.J., Bennett, E.H., Dykstra, L.A., 1993. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265, 1071-1078.
43. Mandler, R.N., Biddison, W.E., Mandler, R., Serrate, S.A., 1986. β-endorphin augments the cytolytic activity and interferon production of natural killer cells. J. Immunol. 136, 934-939.
44. Mansour, A., Fox, C.A., Akil, H., Watson, S.J., 1995. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. TiNS 18, 22-29.
45. Marini, M., Roscetti, G., Bongiorno, L., Urbani, A., Roda, L.G., 1990. Hydrolysis and protection from hydrolysis of enkephalins in human plasma. Neurochem. Res. 15, 61-67.
46. Marini, M., Urbani, A., Bongiorno, L., Roda, L.G., 1992. Hydrolysis and association of leucine enkephalin to lymphomic and erythroleukaemic cell lines: III: Soluble enzymes. Int. J. Immunopharmacol. 14, 995-1002.
47. Marini, M., Urbani, A., Bongiorno, L., Roda, L.G., 1997. Interindividual variability of enkephalin-degrading enzymes in human plasma. Peptides 18, 741-748.
48. Marotti, T., Rabatic, S., Gabrilovac, J.A., 1993. Characterization of the in vivo immunomodulation by met-enkephalin in mice. Int. J. Immunopharmacol. 15, 919-926.
49. Martinez, J.L. Jr., Weinberger, S.B., 1988. Enkephalin hydrolysis in plasma is highly correlated with escape performance in the rat. Behav. Neurosci. 102, 404-408.
50. Masek, K., Petrovicky', P., Seifert, J., 1992. An introduction to the possible role of central nervous system structures in neuroendocrine-immune system interaction. Int. J. Immunopharmacol. 14, 317-322.
51. Mathews, P.M., Froelich, C.J., Sibbitt, W.L. Jr., Bankhurst, A.D., 1983. Enhancement of natural cytotoxicity by β-endorphin. J. Immunol. 130, 1658-1662.
52. McCain, H.W., Bilotta, J., Lamster, I.B., 1987. Endorphinergic modulation of immune function: potent action of the dipeptide glycyl-L-glutamine. Life Sci. 41, 169-176.
53. McCain, H.W., Lamster, I.E., Bozzone, J.M., Grbic, J.T., 1982. β-endorphin modulates human immune activity via non-opiate receptor mechanisms. Life Sci. 31, 1619-1624.
54. Mousa, S.A., Schafer, M., Mitchell, W.M., Hassan, A.H.S., Stein, C., 1996. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur. J. Pharmacol. 311, 221-231.
55. Nieber, K., Baumgarten, C.R., Rathsak, R., Furkert, L., Oehme, P., Kunkel, G., 1992. Substance P and β-endorphin-like immunoreactivity in lavage fluid of subjects with and without allergic asthma. J. Allergy Clin. Immunol. 90, 646-654.
56. Olatunji, O.L., Premilat, S., 1987. Solvent dependent conformation statistics of enkephalins and angiotensin II. Int. J. Pept. Protein Res. 29, 1-8.
57. Pierart, M.E., Najdovski, T., Appelboom, T.E., Deschodt-Lanckman, M.M., 1988. Effect of human endopeptidase-24.11 (enkephalinase) on IL-1-induced thymocyte proliferation activity. J. Immunol. 140, 3808-3811.
58. Plotnikoff, N.P., Miller, G.C., 1983. Enkephalins as immunomodulators. Int. J. Immunopharmacol. 5, 437-441.
59. Roda, L.G., Bongiorno, L., Trani, E., Urbani, A., Marini, M., 1996. Positive and negative immunomodulation by opioid peptides. Int. J. Immunopharmacol. 18, 1-16.
60. Roscetti, G., Possenti, R., Bassano, E., Roda, L.G., 1985. Mechanisms of leu-enkephalin hydrolysis in human blood. Neurochem. Res. 10, 1393-1404.
61. Rottwell, N.J., Hopkins, S.J., 1995. Cytokines and the nervous system: I. Action and mechanisms of action. TiNS 18, 130-136.
62. Rowland, R.R.R., Chukwuocha, R., Tokuda, S., 1987. Modulation of the in vitro immune response by met-enkephalin. Brain Behav. Immun. 1, 342-348.
63. Rowland, R.R.R., Tokuda, S., 1989. Dual immunomodulation by met-enkephalin. Brain Behav. Immun. 3, 171-174.
64. Saksida, L.M., Galea, L.A.M., Kavaliers, M., 1993. Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail Cepaea nemoralis. Peptides 14, 763-765.
65. Schulteis, G., Martinez, J.L. Jr., 1993. Experience-dependent regulation of leu-enkephalin hydrolysis in rat plasma. Peptides 14, 161-167.
66. Schwartz, J.C., Malfroy, B., De La Baume, S., 1981. Biological inactivation of enkephalins and the role of enkephalin-dipeptidil-carboxepeptidase (enkephalinase) as neuropeptidase. Life Sci. 29, 1715-1740.
67. 1-31 on murine splenocyte proliferation via a nalox-one-resistant receptor. Biochem. Biophys. Res. Commun. 3, 936-942.
68. Shaker, M., Shahabi, N.A., Sharp, B.M., 1994. Expression of naloxone-resistant β-endorphin binding sites on A20 cells: effects of concanavalin A and dexamethasone. Immunopharmacology 28, 183-192.
69. Shavit, Y., Lewis, J.W., Terman, G.W., Gale, R.P., Liebeskind, J.C., 1984. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223, 188-190.
70. Smith, E.M., Morrill, A.C., Meyer, W.J. III, Blalock, E.J., 1986. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 321, 881-882.
71. Taub, D.D., Eisenstein, T.K., Geller, E.B., Adler, M.W., Rogers, T.J., 1991. Immunomodulatory activity of μ- and κ-selective opioid agonists. Proc. Natl. Acad. Sci. U.S.A. 88, 360-364.
72. van den Bergh, P., Rozing, J., Nagelkerken, L., 1991a. Two opposing modes of action of β-endorphin on lymphocyte function. Immunology 72, 537-543.
73. van den Bergh, P., Rozing, J., Nagelkerken, L., 1991b. Opioid peptides as cytokines in T cell activation. Adv. Neuroimmunol. 1, 189-203.
74. van den Bergh, P., Rozing, J., Nagelkerken, L., 1993. Identification of two moieties of β-endorphin with opposing effects on rat T cell proliferation. Immunology 79, 18-23.
75. Viveros, O.H., Diliberto, E.J., Hazum, E., Chang, K.J., 1979. Opiate like material in the adrenal medulla. Evidence for storage and secretion with catecholamines. Mol. Pharmacol. 16, 1101-1108.
76. Weber, R.J., Perth, A., 1989. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245, 188-190.
77. Wybran, J., Appelboom, T., Famaey, J.-P., Govaerts, A., 1979. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 123, 1068-1070.
78. 3Hβ-endorphin in rat plasma is increased with chronic stress. Eur. J. Pharmacol. 16, 229-236.
79. Zurawsky, G., Benedik, M., Kamb, B.J., Abrams, J.S., Zurawsky, S.M., Lee, F.D., 1986. Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 232, 772-775.